Skip to main navigation menu Skip to main content Skip to site footer

Review Articles

Vol. 13 No. 3 (2026)

Unveiling the club moss (Lycopodium clavatum L.): Ethnomedicinal uses, phytochemistry and pharmacological insights

DOI
https://doi.org/10.14719/pst.12006
Submitted
26 September 2025
Published
10-09-2026 — Updated on 30-09-2026
Versions

Abstract

Club moss, scientifically known as Lycopodium clavatum L., is a primitive tracheophyte in the family Lycopodiaceae of the pteridophytes. Lycopodium clavatum thrives on exposed, lightly shaded grassland slopes, forest peripheries and disturbed or human-impacted areas such as road cuts. These traits enable them to have widespread distribution in moist forest margins, temperate, subtropical and polar climates. They are documented in Europe, Asia and America. However, according to reports from Plants of the World Online (POWO), the plant is not native to India. The plant is recognised for its considerable ethnomedicinal significance, particularly in homoeopathic remedies across Europe and Asia, where it is used to treat various ailments and contributes to healthcare.  In this review, a comprehensive literature search was performed utilising databases such as Web of Science (WoS), Scopus, PubMed and Google Scholar, employing specific keywords (e.g.,                         "Lycopodium clavatum ethnomedicinal uses," "phytochemicals," "pharmacological activity") up to 2024, concentrating on peer-reviewed English articles and research papers. Ethnomedicinal surveys across more than 10 countries (e.g., Nepal, Bosnia, Canada) document 28 specific uses for 24 ailment categories, including wounds/skin issues (10 reports), respiratory/renal disorders (6 reports), gastrointestinal problems (4 reports), rheumatism/arthritis (3 reports) and others like warts, fever and indigestion. Formulations derived from club moss are predominantly single-plant products (pastes, powders, juices, teas) with rare combinations (e.g., multi-herb teas), mostly from aerial parts/whole plant/spores and no side effects reported in traditional use. Diverse phytoconstituents, including alkaloids, flavonoids and terpenoids, have been reported in the plant. Pharmacological investigations have demonstrated its therapeutic efficacy as an anticancer, antibacterial, anti-inflammatory, hepatoprotective and neuroprotective drug. The plant's potential remains inadequately assessed, with few studies investigating the toxicity of its phytoconstituents. This necessitates further investigation to understand its therapeutic potential and adverse effects. Overall, this review highlights L. clavatum's therapeutic potential and critically evaluates its phytoconstituents, worldwide ethnomedicinal uses and experimentally verified pharmacological properties.

 

References

  1. 1. Lycopodium clavatum. The World Flora Online. Missouri Botanical Garden; c2012–2025. https://www.worldfloraonline.org/taxon/wfo-0001107341
  2. 2. Lycopodium clavatum: taxonomy, morphology, life cycle, ecology and medicinal significance. PrechBio. c2025.
  3. 3. Chauhan M, Chauhan V. Lycopodium clavatum Linn. Vegetable Sulphur – Ayurvedic properties, practical uses & parts used. Planet Ayurveda. c2025.
  4. 4. Lycopodium clavatum. Plant Atlas 2020. c2020. https://plantatlas2020.org/atlas/2cd4p9h.bva
  5. 5. Lycopodium clavatum L. Plants For A Future. c1996–2025. https://pfaf.org/user/Plant.aspx?LatinName=Lycopodium+clavatum
  6. 6. Jensen W. Homoeopathic Lycopodium clavatum (Wolf's foot club moss). J Am Holist Vet Med Assoc. 2024;77:39.
  7. 7. Pathak S, Das JK, Biswas SJ, Khuda-Bukhsh AR. Protective potentials of a potentised homoeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem. 2006;285(1–2):121–31. https://doi.org/10.1007/s11010-005-9065-7
  8. 8. Pathak S, Bhattacharjee N, Das JK, Choudhury SC, Karmakar SR, Banerjee P, et al. Supportive evidence for the anticancerous potential of alternative medicine against hepatocarcinogenesis in mice. Forsch Komplementmed. 2007;14(3):148–56. https://doi.org/10.1159/000103280
  9. 9. Perveen PS, Ali KRM, Veluthoor S, Jijith US, Nithya T, Afiya A, et al. Lycopodium clavatum as an inhibitor of monosodium urate crystallisation in gout: an in vitro study. Indian J Res Homoeopathy. 2022;16(4):263–68. https://doi.org/10.53945/2320-7094.1055
  10. 10. Da Silva GH, Barros PP, Gonçalves GM, Landi MA. Hepatoprotective effect of Lycopodium clavatum 30CH on experimental model of paracetamol-induced liver damage in rats. Homeopathy. 2015;104(1):29–35. https://doi.org/10.1016/j.homp.2014.05.005
  11. 11. Bhalerao R, Praveen O, Mehra P, Rai Y, Choubey G, Sahoo A, et al. Lycopodium clavatum for the management of urolithiasis: a randomised double blind placebo controlled trial. Indian J Res Homoeopathy. 2019;13(3):139–49. https://doi.org/10.4103/ijrh.ijrh_30_19
  12. 12. Martínez-Islas BR, Medel-Flores O, Pérez Soto E, García-Vivas JM, Hernández-Ruíz G, Sánchez-Monroy V, et al. Evaluation of individualised homoeopathic treatment in patients with irritable bowel syndrome: a pilot study. Altern Ther Health Med. 2021;27(S1):158–61.
  13. 13. Leduc C, Coonishish J, Haddad P, Cuerrier A. Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. J Ethnopharmacol. 2006;105(1–2):55–63. https://doi.org/10.1016/j.jep.2005.09.038
  14. 14. Redžić S. The ecological aspect of ethnobotany and ethnopharmacology of population in Bosnia and Herzegovina. Coll Antropol. 2007;31(3):869–90.
  15. 15. Gilca M, Tiplica GS, Salavastru CM. Traditional and ethnobotanical dermatology practices in Romania and other Eastern European countries. Clin Dermatol. 2018;36(3):338–52. https://doi.org/10.1016/j.clindermatol.2018.03.008
  16. 16. Rabearivony AD, Kuhlman AR, Razafiariso ZL, Raharimalala F, Rakotoarivony F, Randrianarivony T, et al. Ethnobotanical study of the medicinal plants known by men in Ambalabe, Madagascar. Ethnobot Res Appl. 2015;14:123–38. https://doi.org/10.17348/era.14.0.123-138
  17. 17. Thapa S. Medico-ethnobotany of Magar community in Salija VDC of Parbat district, central Nepal. Our Nature. 2012;10(1):176–90. https://doi.org/10.3126/on.v10i1.7780
  18. 18. Hossan MS, Roy P, Seraj S, Mou SM, Monalisa MN, Jahan S, et al. Ethnomedicinal knowledge among the Tonchongya tribal community of Roangchaari Upazila of Bandarban district, Bangladesh. Am-Eurasian J Sustain Agric. 2012;6(4):349–59.
  19. 19. Dymek A, Widelski J, Wojtanowski KK, Płoszaj P, Zhuravchak R, Mroczek T. Optimisation of pressurised liquid extraction of Lycopodiaceae alkaloids obtained from two Lycopodium species. Molecules. 2021;26(6):1626. https://doi.org/10.3390/molecules26061626
  20. 20. Jo A, Kim CE, Lee M. Serratane triterpenoids isolated from Lycopodium clavatum by bioactivity-guided fractionation attenuate the production of inflammatory mediators. Bioorg Chem. 2020;96:103632. https://doi.org/10.1016/j.bioorg.2020.103632
  21. 21. Suciu M, Mic FA, Barbu-Tudoran LU, Muntean VA, Gruia AT. Effects of Lycopodium clavatum and Equisetum arvense extracts from Western Romania. Rom Biotechnol Lett. 2017;22(5):13005.
  22. 22. Aleixo CF, Ferraz FN, Massini PF, Lopes CR, Temporini GJ, Aleixo DL, et al. Beneficial immunomodulatory and neurodigestive effect in Trypanosoma cruzi infection after Lycopodium clavatum 13c treatment. Microb Pathog. 2017;112:1–4. https://doi.org/10.1016/j.micpath.2017.09.026
  23. 23. Bastaki SMA, Amir N, Adeghate E, Ojha S. Lycopodium mitigates oxidative stress and inflammation in the colonic mucosa of acetic acid-induced colitis in rats. Molecules. 2022;27(9):2774. https://doi.org/10.3390/molecules27092774
  24. 24. Seth R. The effect of Lycopodium clavatum extracts on apoptosis in SW480 colorectal cancer cells. Int J High Sch Res. 2023;5(5):99–101. https://doi.org/10.36838/v5i5.18
  25. 25. Bhadoria SS, Venkatesan H, Chakraborthy GS. Antimicrobial activity and anti-fungal activity of homoeopathic medicated mustard oil by Lycopodium clavatum Q. Afr J Biomed Res. 2024;27(4 Suppl):1318–21. https://doi.org/10.53555/AJBR.v27i4S.3803
  26. 26. Lycopodium clavatum. RUNNING-PINE. The University and Jepson Herbaria, University of California, Berkeley. c2025.
  27. 27. U.S. Department of Agriculture. Lycopodium clavatum. Washington (DC): USDA; c2025.
  28. 28. Savić J, Mačukanović-Jocić M, Jarić S. Medical ethnobotany on the Javor mountain (Bosnia and Herzegovina). Eur J Integr Med. 2019;27:52–64. https://doi.org/10.1016/j.eujim.2019.02.007
  29. 29. Jarić S, Kostić O, Miletić Z, Marković M, Sekulić D, Mitrović M, et al. Ethnobotanical and ethnomedicinal research into medicinal plants in the Mt Stara Planina region (south-eastern Serbia, Western Balkans). J Ethnobiol Ethnomed. 2024;20(1):7. https://doi.org/10.1186/s13002-024-00647-2
  30. 30. Mattalia G, Stryamets N, Pieroni A, Sõukand R. Knowledge transmission patterns at the border: ethnobotany of Hutsuls living in the Carpathian Mountains of Bukovina (SW Ukraine and NE Romania). J Ethnobiol Ethnomed. 2020;16(1):41. https://doi.org/10.1186/s13002-020-00391-3
  31. 31. Parajuli RR. Study on local uses of medicinal plants in Nayabazar, Pyang and Jamuna VDCs of Ilam District. Nepal J Sci Technol. 2013;14(1):57–66. https://doi.org/10.3126/njst.v14i1.8923
  32. 32. Uprety Y, Asselin H, Boon EK, Yadav S, Shrestha KK. Indigenous use and bio-efficacy of medicinal plants in the Rasuwa District, Central Nepal. J Ethnobiol Ethnomed. 2010;6(1):3. https://doi.org/10.1186/1746-4269-6-3
  33. 33. Singh AG, Gautam LP, Tewari DD. Folk uses of some medicinal plants of Dobhan VDC of Palpa district, Western Nepal. J Phytol. 2011;3(8):62–67.
  34. 34. Rana SK, Oli PS, Rana HK. Traditional botanical knowledge (TBK) on the use of medicinal plants in Sikles area, Nepal. Asian J Plant Sci Res. 2015;5(11):8–15.
  35. 35. Khadka P, Yadav PK. Plants and animals based medicines used by Koch-Rajbanshi of Bhadrapur, Jhapa district, Eastern Nepal. NJBS. 2018;8(1):48–52. https://doi.org/10.3126/njbs.v8i1.51725
  36. 36. Baral BR, Bhagat I. Ethnomedicinal plants used by Dhimal community of Rajghat, Morang. Nepal J Biosci. 2018;8(1):36–47. https://doi.org/10.3126/njbs.v8i1.51724
  37. 37. Gautam RS, Shrestha SJ, Shrestha I. Ethnomedicinal plant resources of Tamang community in the Konjyosom Rural Municipality, Central Nepal. Ethnobot Res Appl. 2023;25:1–29. https://doi.org/10.32859/era.25.56.1-9
  38. 38. Malla B, Gauchan DP, Chhetri RB. An ethnobotanical study of medicinal plants used by ethnic people in Parbat district of western Nepal. J Ethnopharmacol. 2015;165:103–17. https://doi.org/10.1016/j.jep.2014.12.057
  39. 39. Mahara A, Ojha N. Ethnobotanical study of medicinal plants in Kepilasgadhi Rural Municipality of Khotang District, Nepal. Eur J Med Plants. 2024;35(6):105–31. https://doi.org/10.9734/ejmp/2024/v35i61212
  40. 40. Singh AG, Kumar A, Tewari DD, Bharati KA. New ethnomedicinal claims from Magar community of Palpa district, Nepal. Indian J Tradit Knowl. 2018;17(3):499–511.
  41. 41. Xaba VM, Adeniran AL, Lamula SQN, Buwa-Komoreng LV. In vitro bioactivities of plants used against skin diseases in the Eastern Free State, South Africa. Int J Plant Biol. 2024;15(1):13–31. https://doi.org/10.3390/ijpb15010002
  42. 42. Niinuma SA, Khudair AD, Habib H, Khudair AD, MacKenzie G, Atkin SL, et al. Unearthing nature's remedy: an exploration into Lycopodium's medicinal and therapeutic potential. Appl Mater Today. 2024;38:102197. https://doi.org/10.1016/j.apmt.2024.102197
  43. 43. Li X, Kang M, Ma N, Pang T, Zhang Y, Jin H, et al. Identification and analysis of chemical constituents and rat serum metabolites in Lycopodium clavatum using UPLC-Q-TOF/MS combined with multiple data-processing approaches. Evid Based Complement Alternat Med. 2019;2019:5165029. https://doi.org/10.1155/2019/5165029
  44. 44. Pongpamorn P, Wan-erlor S, Ruchirawat S, Thasana N. Lycoclavatumide and 8β,11α-dihydroxylycopodine, a new fawcettimine and lycopodine-type alkaloid from Lycopodium clavatum. Tetrahedron. 2016;72(44):7065–69. https://doi.org/10.1016/j.tet.2016.09.046
  45. 45. Mandal SK, Biswas R, Bhattacharyya SS, Paul S, Dutta S, Pathak S, et al. Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur J Pharmacol. 2010;626(2–3):115–22. https://doi.org/10.1016/j.ejphar.2009.09.033
  46. 46. Ageta H, Iwata K, Ootake Y. Isolation of alpha-onocerin from Lycopodium clavatum Linn. Chem Pharm Bull (Tokyo). 1962;10:637. https://doi.org/10.1248/cpb.10.637
  47. 47. Ansari FR, Ansari WH, Rahman W, Seligmann O, Chari VM, Wagner H. A new acylated apigenin 4′-O-β-D-glucoside from the leaves of Lycopodium clavatum L. Planta Med. 1979;36(7):19–69. https://doi.org/10.1055/s-0028-1097269
  48. 48. Bishayee K, Chakraborty D, Ghosh S, Boujedaini N, Khuda-Bukhsh AR. Lycopodine triggers apoptosis by modulating 5-lipoxygenase and depolarising mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signalling cascade and drug-DNA interaction. Eur J Pharmacol. 2013;698(1–3):110–21. https://doi.org/10.1016/j.ejphar.2012.10.041
  49. 49. Wang Q, Zheng DK, Jiang SP, Li J, Xie Z, He LH, et al. Lycopodium alkaloids from Phlegmariurus carinatus with cytotoxic and neuroprotective effects. Chem Biodivers. 2023;20(12):e202301449. https://doi.org/10.1002/cbdv.202301449
  50. 50. Giang VH, Thuy LT, Hanh TTH, Cuong NX, Vinh LB, Ban NK, et al. Cytotoxic and nitric oxide inhibitory activities of triterpenoids from Lycopodium clavatum L. Nat Prod Res. 2022;36(24):6232–39. https://doi.org/10.1080/14786419.2021.2024824
  51. 51. Zhou W, Kang F, Huang L, Li J, Wang W, Xiao L, et al. Serratane triterpenoids from Lycopodium complanatum and their anti-cancer and anti-inflammatory activities. Bioorg Chem. 2020;101:103959. https://doi.org/10.1016/j.bioorg.2020.103959
  52. 52. Das S, Das J, Paul A, Samadder A, Khuda-Bukhsh AR. Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage. J Acupunct Meridian Stud. 2013;6(5):252–62. https://doi.org/10.1016/j.jams.2013.07.002
  53. 53. Trofimova NN, Gromova AS, Semenov AA. Serratene triterpenoids from Lycopodium clavatum L. (Lycopodiaceae). Russ Chem Bull. 1996;45:961–63. https://doi.org/10.1007/BF01431333
  54. 54. Srivastava S, Singh AP, Rawat AK. A HPTLC method for the identification of ferulic acid from Lycopodium clavatum. Asian Pac J Trop Biomed. 2012;2(1 Suppl):S12–S14. https://doi.org/10.1016/S2221-1691(12)60121-X
  55. 55. Kucukbagriacik Y, Dastouri M, Yilmaz H, Altuntas EG. The apoptotic effect of the Lycopodium clavatum extracts on MCF-7 human breast cancer cells. Med Oncol. 2023;40:289. https://doi.org/10.1007/s12032-023-02159-7
  56. 56. Da Sur RK, Samajdar K, Mitra S, Gole MK, Chakrabarty BN. Hepatoprotective action of potentized Lycopodium clavatum L. Br Hom J. 1990;78(3):152–56. https://doi.org/10.1016/S0007-0785(05)80334-5
  57. 57. Descallar AL, Nuñez MP, Cabrera ML, Martin TT, Obemio CD, Lañojan RS. Phytochemical analysis and antioxidant capacity of Lycopodium clavatum Linn. from Lake Sebu, South Cotabato, Philippines. In: AIP Conf Proc. 2017;1803:020021. https://doi.org/10.1063/1.4973148
  58. 58. Orhan I, Ozçelik B, Aslan E, Sinem K, Murat K, Taner S, et al. Antioxidant and antimicrobial actions of the clubmoss Lycopodium clavatum L. Phytochem Rev. 2007;6:189–96. https://doi.org/10.1007/s11101-006-9053-x
  59. 59. Thomasson MJ, Diego-Taboada A, Barrier S, Martin-Guyout J, Amedjou E, Atkin SL, et al. Sporopollenin exine capsules (SpECs) derived from Lycopodium clavatum provide practical antioxidant properties by retarding rancidification of an ω-3 oil. Ind Crops Prod. 2020;154:112714. https://doi.org/10.1016/j.indcrop.2020.112714
  60. 60. Konrath EL, Neves BM, Lunardi PS, dos Santos Passos C, Simões-Pires A, Ortega MG, et al. Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used Lycopodium species from South America on alkaloid extracts. J Ethnopharmacol. 2012;139(1):58–67. https://doi.org/10.1016/j.jep.2011.10.042
  61. 61. Dastouri MR, Küçükbağrıaçık Y. Apoptotic effects of Lycopodium clavatum extract on SKBR-3 human breast cancer cells. Cukurova Med J. 2023;48(4):1207–16. https://doi.org/10.17826/cumj.1336606
  62. 62. Paramita P, Subramaniam VD, Murugesan R, Gopinath M, Ramachandran I, Ramalingam S, et al. Evaluation of potential anticancer activity of cationic liposomal nanoformulated Lycopodium clavatum in colon cancer cells. IET Nanobiotechnol. 2018;12(6):727–32. https://doi.org/10.1049/iet-nbt.2017.0106
  63. 63. Samadder A, Das S, Das J, Paul A, Boujedaini N, Khuda-Bukhsh AR. The potentized homoeopathic drug, Lycopodium clavatum (5C and 15C) has anticancer effect on HeLa cells in vitro. J Acupunct Meridian Stud. 2013;6(4):180–87. https://doi.org/10.1016/j.jams.2013.04.004
  64. 64. Banerjee A, Pathak S, Jothimani G, Roy S. Antiproliferative effects of combinational therapy of Lycopodium clavatum and quercetin in colon cancer cells. J Basic Clin Physiol Pharmacol. 2020;31(4):jbcpp-2019-0193. https://doi.org/10.1515/jbcpp-2019-0193
  65. 65. Valle ACV, de Carvalho AC, Rahme SW, Araujo ARB, Malard PF, Sena Brunel HS. Comparison of homoeopathic medicines composed of Taraxacum officinale and Lycopodium clavatum for treating cellular hepatocarcinoma. Med Res Arch. 2023;11(8):1–9. https://doi.org/10.18103/mra.v11i8.4373
  66. 66. Pathak S, Banerjee A, Khuda-Bukhsh AR. Efficacy of ethanolic spore extract of Lycopodium clavatum in reducing induced hepatotoxicity and genotoxicity in mice. Int J Biol Chem Sci. 2010;4(3):770–81. https://doi.org/10.4314/ijbcs.v4i3.60510
  67. 67. Almaguer-Flores A, González-Alva P. Antibacterial activity of homoeopathic medications Lycopodium clavatum and Arsenicum album against periodontal bacteria. Odovtos Int J Dent Sc. 2018;20(2):71–79. https://doi.org/10.15517/ijds.v20i2.32807
  68. 68. Jagadeesan AJ, Bhatia M, Vimala Devi S, Meera M, Madhumala G, Suresh A, et al. Protective effect of ethanolic extract of Lycopodium clavatum against pathogenic Escherichia coli and Proteus vulgaris. Chettinad Health City Med J. 2021;10(1):4–9. https://doi.org/10.36503/chcmj10(1)-02
  69. 69. Sebastian AS, Kuriakose R. Antibacterial activity of various homoeopathic medicines against different bacterial strains. Int J Adv Res Sci Commun Technol. 2025;5(12):623–31.
  70. 70. Dyab AK, Mohamed MA, Meligi NM, Mohamed SK. Encapsulation of erythromycin and bacitracin antibiotics into natural sporopollenin microcapsules: antibacterial, cytotoxicity, in vitro and in vivo release studies for enhanced bioavailability. RSC Adv. 2018;8(58):33432–444. https://doi.org/10.1039/C8RA05499A
  71. 71. Hanif K, Kumar M, Singh N, Shukla R. Effect of homoeopathic Lycopodium clavatum on memory functions and cerebral blood flow in memory-impaired rats. Homeopathy. 2015;104(1):24–28. https://doi.org/10.1016/j.homp.2014.08.003
  72. 72. Jayaraj RL, Beiram R, Azimullah S, Meeran MFN, Ojha SK, Adem A, et al. Lycopodium attenuates loss of dopaminergic neurons by suppressing oxidative stress and neuroinflammation in a rat model of Parkinson’s disease. Molecules. 2019;24(11):2182. https://doi.org/10.3390/molecules24112182
  73. 73. Chatterjee M, De A, Sadhukhan GC, Kundu JK. Ameliorative effects of the homoeopathic medicine Lycopodium 200c and extract of Phyllanthus emblica in cadmium-induced neurotoxicity in mice. Curr Sci. 2016;111(8):1368–71. https://doi.org/10.18520/cs/v111/i8/1368-1371
  74. 74. Lopes CR, Falkowski GJ, Brustolin CF, Massini PF, Ferreira ÉC, Moreira NM, et al. Highly diluted medication reduces tissue parasitism and inflammation in mice infected by Trypanosoma cruzi. Homeopathy. 2016;105(2):186–93. https://doi.org/10.1016/j.homp.2015.09.005
  75. 75. Pereira AV, Lera KR, Miranda MM, Drozino RN, Falkowski-Temporini GJ, Góis MB, et al. Safety and efficacy of Lycopodium clavatum 200dH in Toxoplasma gondii infected mice. Eur J Integr Med. 2016;8(4):540–45. https://doi.org/10.1016/j.eujim.2016.03.004
  76. 76. Rathor RS, Aggarwal A, Reddy ESR, Sharma P, Singh C, Chakraborty PK. A study to ascertain the effect of Berberis vulgaris, Hydrangea, Cantharis, Lycopodium clavatum and Staphysagria in renal calculi. Int J Hom Sci. 2021;5(1):25–28. https://doi.org/10.33545/26164485.2021.v5.i1a.287
  77. 77. Shakdvipiya Y, Mhaishale MA, Nagar G, Jain A. Individualised homoeopathic medicine for urolithiasis comorbid with cholelithiasis and LUTS: a case report. IRJMS. 2024;5(1):744–49. https://doi.org/10.47857/irjms.2024.v05i01.0362
  78. 78. Katravatu NN, Thiyagapriya C, Saravanan G. 19 mm urolithiasis expelled with homoeopathic medicine: a case report. Sustain Agric Food Environ Res. 2023;13(Special Issue):1–8.
  79. 79. Sharma SM, Rana V, Jain S, Singh Kushwaha N, Sulekha K, Mishra S. An evidence-based case report of urolithiasis treated with homoeopathy. World J Pharm Res. 2025;14(13):1683–89. https://doi.org/10.20959/wjpr.202513-37461
  80. 80. Hati AK, Rath S, Nayak C, Raj I, Sahoo AR, Paital B. Successful treatment of ureteric calculi with constitutional homoeopathic medicine Lycopodium clavatum: a case report. J Drug Deliv Ther. 2018;8(6):1–7. https://doi.org/10.22270/jddt.v8i6.2043
  81. 81. Yuvaneshwaran AR, Sugathan NV, Harisankar V, Arjun M, Jintu J. A retrospective study on the efficacy of Lycopodium clavatum 200CH and Eucalyptus 30CH in the treatment of chronic kidney diseases. Int J Creat Res Thoughts. 2025;13(1):19–24.
  82. 82. Sadiq M, Mujawar N, Reddy RY. A case study: bilateral nephrolithiasis and associated pyelonephritis by individualised homoeopathic medicine Lycopodium clavatum. Int J Innov Res Technol. 2025;12(3):691–95.
  83. 83. Chowdhury AK, Islam MM, Rasel NEA, Cordero LMA. Clinical efficacy of homoeopathy in the treatment of simple kidney cysts. Indian J Integr Med. 2024:1–5.
  84. 84. Mahawer N, Arya B. Clinical verification of individualised homoeopathic medicine Lycopodium clavatum in atopic hand dermatitis: a case study. Homoeopathy 360. c2025.
  85. 85. Yadav A, Dixit A, Arya B, Kumari Y, Mahiya S, Kumar D. Case of alopecia areata treated successfully with the help of Lycopodium clavatum: a case report. Indian J Res Homoeopathy. 2021;5(4):181–83. https://doi.org/10.33545/26164485.2021.v5.i4c.470
  86. 86. Rathore K. A case report on wart treated successfully by individualised homoeopathic medicine. Int J Homeopath Nat Med. 2023;9(1):1–5. https://doi.org/10.11648/j.ijhnm.20230901.11

Downloads

Download data is not yet available.